WHO es­ti­mates funds for elim­i­nat­ing measles in In­dia

BioSpectrum (India) - - WHO NEWS -

World Health Or­ga­ni­za­tion (WHO) es­ti­mates that around $800 mil­lion is re­quired to elim­i­nate measles by 2020 from In­dia and other coun­tries of south and south east Asia. Measles is one of the ma­jor causes of death in chil­dren, MMR (measles, mumps and rubella) jabs are one of the ma­jor pub­lic health in­ter­ven­tions aimed at elim­i­nat­ing child­hood deaths. For un­ham­pered progress against the vi­ral dis­ease, WHO states that a to­tal of 400 mil­lion chil­dren in In­dia, Bangladesh, Myan­mar, Ti­mor Leste and In­done­sia must re­ceive the Measles Rubella (MR) vac­cine by 2018, while 140 mil­lion should be reached by the end of 2017. In 2015, the Na­tional Tech­ni­cal Ad­vi­sory Group on Im­mu­niza­tion in In­dia rec­om­mended in­tro­duc­tion of a com­bined measles-rubella vac­cine, as a na­tion-wide cam­paign cover­ing chil­dren in the age group of nine months to 15 years.

Af­ter the cam­paign, the MR vac­cine will re­place the cur­rent two doses of measles vac­cine. The on­go­ing MR cam­paign in five states and union ter­ri­to­ries—Tamil Nadu, Kar­nataka, Goa, Puducherry and Lak­shad­weep—to vac­ci­nate 34.8 mil­lion chil­dren, has till date, reached 11.6 mil­lion chil­dren.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.